Clinical Characteristics of Patients with Drug-induced Liver Injury

被引:13
|
作者
Yang, Li-Xia [1 ]
Liu, Cheng-Yuan [2 ]
Zhang, Lun-Li [1 ]
Lai, Ling-Ling [1 ]
Fang, Ming [2 ]
Zhang, Chong [3 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Infect Dis, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Emergency, Nanchang 330006, Jiangxi, Peoples R China
[3] Nanchang Univ, Coll Med, Dept Clin Med, Nanchang 330006, Jiangxi, Peoples R China
关键词
Clinical Characteristics; Drug-induced Liver Injury; Pathology; INDUCED HEPATOTOXICITY;
D O I
10.4103/0366-6999.197995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Drug is an important cause of liver injury and accounts for up to 40% of instances of fulminant hepatic failure. Drug-induced liver injury (DILI) is increasing while the diagnosis becomes more difficult. Though many drugs may cause DILI, Chinese herbal medicines have recently emerged as a major cause due to their extensive use in China. We aimed to provide drug safety information to patients and health carers by analyzing the clinical and pathological characteristics of the DILI and the associated drug types. Methods: A retrospective analysis was conducted in 287 patients diagnosed with DILI enrolled in our hospital from January 2011 to December 2015. The categories of causative drugs, clinical and pathological characteristics were reviewed. Results: Western medicines ranked as the top cause of DILI, accounting for 163 out of the 287 DILI patients (56.79%) in our study. Among the Western medicine, antituberculosis drugs were the highest cause (18.47%, 53 patients) of DILI. HAIR SPACE Antibiotics (18 patients, 6.27%) and antithyroid (18 patients, 6.27%) drugs also ranked among the major causes of DILI. Chinese herbal medicines are another major cause of DILI, accounting for 36.59% of cases (105 patients). Most of the causative Chinese herbal medicines were those used to treat osteopathy, arthropathy, dermatosis, gastropathy, leukotrichia, alopecia, and gynecologic diseases. Hepatocellular hepatitis was prevalent in DILI, regardless of Chinese herbal medicine or Western medicine-induced DILI. Conclusions: Risks and the rational use of medicines should be made clear to reduce the occurrence of DILI. For patients with liver injury of unknown origin, liver tissue pathological examination is recommended for further diagnosis.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [41] Drug-induced liver injury: past, present and future
    Daly, Ann K.
    PHARMACOGENOMICS, 2010, 11 (05) : 607 - 611
  • [42] Serum proteomic profiling in patients with drug-induced liver injury
    Bell, L. N.
    Vuppalanchi, R.
    Watkins, P. B.
    Bonkovsky, H. L.
    Serrano, J.
    Fontana, R. J.
    Wang, M.
    Rochon, J.
    Chalasani, N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (05) : 600 - 612
  • [43] Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
    Shao, Qihui
    Mao, Xinyu
    Zhou, Zhixuan
    Huai, Cong
    Li, Zhiling
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Drug-induced liver injury: what was new in 2008?
    Liss, Gordon
    Lewis, James H.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) : 843 - 860
  • [45] Drug-induced Liver Injury Caused by Intravenously Administered Medications: The Drug-induced Liver Injury Network Experience
    Ghabril, Marwan
    Fontana, Robert
    Rockey, Don
    Jiezhun, Gu
    Chalasani, Naga
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (06) : 553 - 558
  • [46] Translating new knowledge on drug-induced liver injury into clinical practice
    Hernandez, Nelia
    Pontet, Yessica
    Bessone, Fernando
    FRONTLINE GASTROENTEROLOGY, 2020, 11 (04) : 303 - 310
  • [47] Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types
    Chong Zhang
    Yuyu Wu
    Suyu Yuan
    Xiaoguang Dou
    Qiuju Sheng
    Jingyan Wang
    Wenyue Tian
    Lan Yao
    Yang Ding
    Digestive Diseases and Sciences, 2020, 65 : 3360 - 3368
  • [48] Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types
    Zhang, Chong
    Wu, Yuyu
    Yuan, Suyu
    Dou, Xiaoguang
    Sheng, Qiuju
    Wang, Jingyan
    Tian, Wenyue
    Yao, Lan
    Ding, Yang
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (11) : 3360 - 3368
  • [49] Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients
    Kowalec, Kaarina
    Kingwell, Elaine
    Yoshida, Eric M.
    Marrie, Ruth Ann
    Kremenchutzky, Marcelo
    Campbell, Trudy L.
    Wadelius, Mia
    Carleton, Bruce
    Tremlett, Helen
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (10) : 1305 - 1317
  • [50] Drug Rechallenge Following Drug-Induced Liver Injury
    Hunt, Christine M.
    Papay, Julie I.
    Stanulovic, Vid
    Regev, Arie
    HEPATOLOGY, 2017, 66 (02) : 646 - 654